HBsAg seroclearance in asymptomatic carriers of high endemic areas: Appreciably high rates during a long‐term follow‐up

Spontaneous hepatitis B surface antigen (HBsAg) seroclearance in chronic HBV infection has long been suggested as a rare event in high endemic areas. The prevalence of HBsAg in the general population of Taiwan, however, decreased remarkably from 15%‐20% before age 40 to 5%‐10% after age 60 or 70. This study aimed to reexamine the rates of HBsAg seroclearance by a long‐term follow‐up of 1965 hepatitis B e antibody–positive asymptomatic adult carriers. Of these, 1076 (55%) were males, the mean (± SD) age was 35.6 ± 9.2 years and the mean follow‐up was 10.8 ± 5.4 years. Hepatitis relapsed in 314 patients, 0.5 to 18 (mean ± SD = 5.8 ± 4.4) years after the entry. The probability of hepatitis relapse correlated positively with male sex (P < 0.0001) and age at entry (P < 0.0001). Serum HBsAg cleared in 245 patients at the mean age of 47.8 ± 9.6 years. The cumulative probabilities of HBsAg seroclearance were 8.1% after 10 years, but increased disproportionally to 24.9% and 44.7%, respectively, after 20 and 25 years. In multivariate analysis, the probability of HBsAg seroclearance correlated positively with age at entry (P < 0.0001) and sustained remission of hepatitis (P < 0.0001) and marginally significantly with male sex (P = 0.053). Conclusion: Cumulative rate of HBsAg seroclearance in asymptomatic adult carriers from high endemic areas was approximately 40% after 25 years of follow‐up. The low HBsAg seroclearance rates in previous studies might be due to the relative short period of follow‐up. (HEPATOLOGY 2007;45:1187–1192.)

[1]  J. Sung,et al.  A seroepidemiologic study of hepatitis B virus infection in Taiwan. , 1978, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association.

[2]  R. Sampliner,et al.  The Liver Histology and Frequency of Clearance of the Hepatitis B Surface Antigen (HBsAg) in Chronic Carriers , 1979, The American journal of the medical sciences.

[3]  Y. Chiang,et al.  Hepatitis B virus infection in Taiwan with reference to anti-HBc versus HBsAg and anti-HBs. , 1980, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association.

[4]  B. Berris,et al.  Results of long-term prospective study of the hepatitis B surface antigen (HBsAg) carrier state. , 1982, Hepato-gastroenterology.

[5]  C. Chu,et al.  Sex Difference in Chronic Hepatitis B Virus Infection: An Appraisal Based on the Status of Hepatitis B e Antigen and Antibody , 2007, Hepatology.

[6]  Ding‐Shinn Chen,et al.  Epidemiological Study on Hepatitis B Virus infection in Taiwan , 1984 .

[7]  H. Thomas,et al.  Natural history of chronic hepatitis B virus infection in taiwan: Studies of hepatitis B virus DNA in serum , 1985, Hepatology.

[8]  H. Hsu,et al.  Clearance of hepatitis B surface antigen (HBsAg) after surgical resection of hepatocellular carcinoma. , 1987, Journal of hepatology.

[9]  C. Chu,et al.  Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: A prospective study , 1991, Hepatology.

[10]  Y. Liaw,et al.  Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: A longitudinal study , 1993, Journal of clinical ultrasound : JCU.

[11]  G. Meucci,et al.  The Natural History of Asymptomatic Hepatitis B Surface Antigen Carriers , 1993, Annals of Internal Medicine.

[12]  C. J. Chen,et al.  Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. , 1997, American journal of epidemiology.

[13]  F. Chang,et al.  Sero‐clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis , 1998, Hepatology.

[14]  C. Chu.  Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma , 2000, Journal of gastroenterology and hepatology.

[15]  B. McMahon,et al.  Serologic and Clinical Outcomes of 1536 Alaska Natives Chronically Infected with Hepatitis B Virus , 2001, Annals of Internal Medicine.

[16]  A. Lok,et al.  Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. , 2002, Gastroenterology.

[17]  C. Chu,et al.  Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. , 2002, Gastroenterology.

[18]  C. Siu,et al.  HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects , 2004, Hepatology.

[19]  C. Chu,et al.  Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. , 2004, The American journal of medicine.

[20]  Ding‐Shinn Chen,et al.  Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers , 2004, Journal of medical virology.

[21]  C. Chu,et al.  Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels at baseline. , 2005, Journal of hepatology.

[22]  M. Yuen,et al.  Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications , 2005, Gut.

[23]  Y. N. Park,et al.  Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. , 2005, Journal of hepatology.

[24]  Yoshiyuki Suzuki,et al.  Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B. , 2006, The American journal of medicine.

[25]  V. Alves,et al.  Spontaneous hepatitis B surface antigen clearance in a long-term follow-up study of patients with chronic type B hepatitis. Lack of correlation with hepatitis C and D virus superinfection , 1996, Journal of Gastroenterology.